The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.


Time/Date Code Headline Source Impact
08:26 04-Nov-2015 IMM Lupuzor Phase III Pivotal Trial Update RNS +0.97% Up
07:00 04-Nov-2015 IMM Lupuzor Phase III Pivotal Trial Update RNS +0.97% Up
07:00 23-Oct-2015 IMM Directorate Change RNS -10.03% Down
07:05 30-Sep-2015 IMM Directorate Change RNS -4.46% Down
07:00 30-Sep-2015 IMM Interim Results RNS -4.46% Down
07:00 29-Jul-2015 IMM Richard Warr RNS +5.86% Up
07:00 25-Jun-2015 IMM Lupuzor's Founder Dr Slyviane Muller Awarded Medal RNS -3.91% Down
12:50 29-May-2015 IMM Result of AGM RNS +1.44% Up
15:44 06-May-2015 IMM Annual Report & Accounts RNS -3.60% Down
07:02 06-May-2015 IMM Interim Board Change RNS -3.60% Down
07:05 30-Apr-2015 IMM Directorate Change RNS -3.88% Down
07:00 30-Apr-2015 IMM Preliminary Results RNS -3.88% Down
12:02 11-Feb-2015 IMM CANCER UPDATE: IPP-204106 RNS -1.66% Down
07:00 27-Jan-2015 IMM Enterprise Investment Scheme Status RNS +0.97% Up
07:00 22-Jan-2015 IMM Collaboration Agreement with Simbec-Orion RNS +7.76% Up

Price changes are calculated on the basis of the following formula: [ avg(x) - avg(y)] / avg(y) where:
x = instrument's 7 closing prices after the news has been released
y = instrument's latest 7 closing prices before the news was released, including the day of the release of the news

Please note that the news releases are only one of the multiple factors that could have had an impact on the change in the security’s price over the time period analysed by the News Analysis tool. Where data are insufficient the graph does not show any price change and the table below the graph displays a blank “ - “ next to the line indicating the RNS issue.

Company Information
Updated Monthly
Company address 50 Broadway, Westminster, London, SW1H 0BL, United Kingdom
Company website http://www.immupharma.c...
Market cap(in millions)* £ 20.16
Listing/Admission to trading 17 Feb 2006
Trading service SETSqx
Market AIM
Listing category -
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

Trading Information
FTSE index FTSE AIM All-Share,FTSE AIM All-Share - Health Care
FTSE sector Pharmaceuticals & Biotechnology
FTSE sub-sector Biotechnology
Country of share register GB
Segment ASQ1
MiFID Status MTF
Exchange market size 5,000
SEDOL 3371101
ISIN number GB0033711010

IMMUPHARMA share - news analysis